MENSTRUAL-CYCLE EFFECTS ON CAFFEINE ELIMINATION IN THE HUMAN FEMALE

被引:129
作者
LANE, JD
STEEGE, JF
RUPP, SL
KUHN, CM
机构
[1] DUKE UNIV,MED CTR,DEPT OBSTET & GYNECOL,DURHAM,NC 27710
[2] DUKE UNIV,MED CTR,DEPT PHARMACOL,DURHAM,NC 27710
关键词
CAFFEINE; MENSTRUAL CYCLE; PHARMACOKINETICS; FEMALES;
D O I
10.1007/BF02285099
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Increases in the levels of sex steroids due to pregnancy or oral contraceptive steroid use are known to decrease significantly the rate at which caffeine is eliminated from the body. An investigation has now been made into whether the changes in sex steroid levels that occur during normal menstrual cycling also affect the rate of caffeine elimination, especially whether hormonal shifts in the luteal phase are associated with slower elimination of caffeine. Repeated 24-hour caffeine elimination studies were conducted during the follicular and luteal phases of the menstrual cycle in 10 healthy women. Comparisons of the follicular and luteal phases revealed that systemic clearance of caffeine was slower in the luteal phase, although the t1/2 did not differ. The slowing effect was related to the proximity to onset of menstruation and to levels of progesterone. The evidence suggests that caffeine elimination may be slowed in the late luteal phase, prior to the onset of menstruation. Such a reduction would lead to increased accumulation of caffeine with repeated self-administration during the day, but the effect may be too small to be of clinical significance in the majority of women.
引用
收藏
页码:543 / 546
页数:4
相关论文
共 11 条
[1]   IMPAIRMENT OF CAFFEINE CLEARANCE BY CHRONIC USE OF LOW-DOSE ESTROGEN-CONTAINING ORAL-CONTRACEPTIVES [J].
ABERNETHY, DR ;
TODD, EL .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 28 (04) :425-428
[2]  
ALDRIDGE A, 1981, SEMIN PERINATOL, V5, P310
[3]  
BALOGH A, 1987, ZBL GYNAKOL, V109, P1135
[4]  
Barone J. J., 1984, CAFFEINE PERSPECTIVE, P59
[5]  
CALLAHAN MM, 1983, DRUG METAB DISPOS, V11, P211
[6]  
COOK CE, 1976, J PHARMACOL EXP THER, V199, P679
[7]  
GREDEN JF, 1974, AM J PSYCHIAT, V131, P1089
[8]  
NEIMS AH, 1983, NUTR BRAIN, V6, P1
[9]  
PATWARDHAN RV, 1980, J LAB CLIN MED, V95, P604
[10]  
REITVELD EC, 1984, EUR J CLIN PHARMACOL, V26, P371